Labiana Health, S.A. (BME:LAB)
Spain · Delayed Price · Currency is EUR 6.55
0.00 (0.00%)
Last updated: Aug 6, 2026, 4:07 PM CET
Labiana Health Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 1.2 | -0.03 | -5.28 | -7.84 | -2.12 |
Depreciation & Amortization | 3.79 | 4.25 | 5.09 | 4.84 | 5 |
Other Adjustments | 5.43 | 4.78 | 3.28 | 4.97 | 2.44 |
Change in Receivables | -1.31 | 2.86 | -1.64 | -0.82 | 3.14 |
Changes in Inventories | -2.56 | -1.2 | 1.12 | 1.09 | -0.85 |
Changes in Accounts Payable | 1.64 | 1.56 | -1.96 | 4.28 | -0.61 |
Changes in Accrued Expenses | 0.12 | -0.09 | 0.6 | 0 | -0 |
Changes in Income Taxes Payable | -0.51 | -0.09 | -0.05 | -0.13 | -1.08 |
Changes in Other Operating Activities | -6.1 | -4.85 | -2.98 | -1.71 | -2.02 |
Operating Cash Flow | 1.7 | 7.19 | -1.83 | 4.68 | 3.91 |
Operating Cash Flow Growth | -76.37% | - | - | 19.77% | 3.10% |
Capital Expenditures | -4.36 | -3.02 | -1.66 | -2.78 | -2.3 |
Sale of Property, Plant & Equipment | - | 0 | 0.02 | - | - |
Purchases of Intangible Assets | -0.08 | -0.03 | -1.19 | -2.67 | -2.47 |
Proceeds from Sale of Intangible Assets | - | - | 0.31 | - | - |
Purchases of Investments | - | -0.93 | -0.06 | -0.93 | -3.72 |
Proceeds from Sale of Investments | 0.2 | 0.03 | 0.56 | 3.44 | - |
Cash Acquisitions | - | -0.04 | - | - | -1.1 |
Proceeds from Business Divestments | - | - | - | - | 2.36 |
Investing Cash Flow | -4.24 | -3.99 | -2.03 | -2.95 | -7.23 |
Long-Term Debt Issued | 4.25 | 4.37 | 19.55 | 0.74 | 8.74 |
Long-Term Debt Repaid | -2.74 | -3.64 | -16.35 | -7.41 | -2.56 |
Net Long-Term Debt Issued (Repaid) | 1.51 | 0.73 | 3.2 | -6.67 | 6.18 |
Issuance of Common Stock | - | - | 1.26 | 4.59 | - |
Repurchase of Common Stock | 0.21 | -0.16 | -0.16 | -0.41 | - |
Net Common Stock Issued (Repurchased) | 0.21 | -0.16 | 1.1 | 4.17 | - |
Other Financing Activities | - | - | - | - | -1.13 |
Financing Cash Flow | 1.72 | 0.57 | 4.3 | -2.5 | 5.06 |
Net Cash Flow | -0.82 | 3.78 | 0.44 | -0.76 | 1.74 |
Free Cash Flow | -2.66 | 4.18 | -3.48 | 1.9 | 1.61 |
Free Cash Flow Growth | - | - | - | 17.72% | - |
FCF Margin | -3.53% | 6.30% | -5.96% | 3.28% | 2.83% |
Free Cash Flow Per Share | -0.37 | 0.58 | -0.48 | 0.26 | 0.26 |
Levered Free Cash Flow | -3.89 | -2.44 | -1.07 | -10.03 | 2.56 |
Unlevered Free Cash Flow | 7.44 | -37.57 | -1.19 | -1.47 | -1.24 |